Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Drive R&D Innovations
Antengene Corporation has announced the appointment of Dr. Bing Hou as its new Chief Scientific Officer. This strategic move aims to enhance the company's research and development efforts and advance its next-generation therapeutic pipeline.